Products
UK regulator says tech tools aren’t a ‘silver bullet’
‘Miscalibration’ and a lack of due diligence ‘can lead to very poor outcomes’
Coronavirus is covered by most health insurers
As many providers do not require policy changes or add-ons for their clients
Alternatives | 4 Feb 20
Second medicinal cannabis fund rolled out in Europe
It is domiciled in Guernsey with a minimum investment of £25,000
FCA must ‘act quicker’ against phoenixing firms
Momentum boss flags ‘staggering’ adviser fragmentation but says fees could rebound in 2020
AMP to reduce superannuation fees
To provide ‘highly competitive wealth solution to help with retirement’